Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-07-12

Clinical Trial Update: Ivermectin and Human Immunity [EARLY_Phase 1]

View source ↗

Summary

Early phase 1 trial investigating ivermectin and its effects on human immunity has been completed with results posted in 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • IVERMECTIN (Ivermectin)

Snippet

Sponsor: University of Georgia | Conditions: Ivermectin | EARLY_Phase 1 | Status: COMPLETED | Results posted: 2019-07-12